Dermal medicine composition containing fluticasone propionate and nitric oxide synthase (NOS) inhibitor

A technology of fluticasone propionate and a composition, which is applied in the field of pharmaceutical compositions for skin, can solve problems such as large irritation and poor compliance, and achieve the effects of promoting absorption, inhibiting the reduction of local immunity and alleviating symptoms

Inactive Publication Date: 2013-06-05
TIANJIN JINYAO GRP
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, we found that drugs such as S-methylisothiourea and aminoguanidine, due to their own chemical properties, when used for external use, have greater irritation during treatment, resulting in poor compliance

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Dermal medicine composition containing fluticasone propionate and nitric oxide synthase (NOS) inhibitor
  • Dermal medicine composition containing fluticasone propionate and nitric oxide synthase (NOS) inhibitor

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] L-N6-(1-iminoethyl)-lysine 5g, appropriate amount of sodium chloride, sodium carboxymethylcellulose 2.5g, poloxamer 0.5g, fluticasone propionate 0.5g, the rest of water for injection

[0033] Preparation method: Dissolve the carboxymethylcellulose sodium and poloxamer of the prescribed amount in 500ml water for injection, stir to dissolve, add the prescribed amount of L-N6-(1-iminoethyl)-lysine, Adjust the pH to 5.5. Add the prescribed amount of fluticasone propionate micropowder, and add the remaining amount of water for injection. Adjust to isotonicity with sodium chloride and dispense. The obtained composition NOS inhibitor % = 03%, fluticasone propionate % = 0.05%.

Embodiment 2

[0034] Embodiment 2 gel

[0035] N-monomethyl-L-arginine 10g, glycerin 50ml, carbomer 9342g,

[0036] Fluticasone propionate 1g,

[0037] Take the prescribed amount of Carbomer 934 and add glycerol to moisten and grind, add 500ml of purified water to swell as a gel matrix, add the prescribed amount of fluticasone propionate micropowder into the gel matrix and stir well, then add the prescribed amount of N -Monomethyl-L-arginine, dissolved in an appropriate amount of water, slowly added to the gel matrix and stirred evenly, adjusted the pH value to 5.5 with an appropriate amount of 1mol / L sodium hydroxide, and added the rest of the water. The obtained composition NOS inhibitor % = 1%, fluticasone propionate = 0.1%.

Embodiment 2-1

[0039] Prescription is identical with embodiment 2, gets menthol 10g in addition, dissolves in the prescription quantity glycerol, other preparation methods are identical with embodiment 2.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
Login to view more

Abstract

A dermal medicine composition containing fluticasone propionate and a nitric oxide synthase (NOS) inhibitor comprises the fluticasone propionate used as an active ingredient, an amino acid derivative used as the NOS inhibitor, one type or a plurality of types of medicine auxiliary materials suitable for skins and the balance water.

Description

technical field [0001] The invention relates to a pharmaceutical composition, which is a pharmaceutical composition for skin containing corticosteroids and NOS inhibitors. Background technique [0002] Glucocorticoids have anti-inflammatory, anti-allergic, anti-rheumatic, and immunosuppressive effects, and are widely used in the treatment of allergic and autoimmune inflammatory diseases. Such as connective tissue disease, active rheumatism, rheumatoid arthritis, lupus erythematosus, severe bronchial asthma, severe dermatitis, ulcerative colitis, acute leukemia, etc. It is also used for some serious infections, poisoning, and malignant lymphoma. treat. [0003] Skin inflammations such as eczema, allergic dermatitis, atopic dermatitis, and urticaria are all allergic reactions caused by certain allergens, resulting in skin inflammation and skin allergies There are many kinds of allergens that react, among which infections such as viruses, fungi, and bacteria are one of the im...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/56A61K31/198A61K47/14A61P17/00A61P29/00
Inventor 孙亮陈松赵琳
Owner TIANJIN JINYAO GRP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap